Virginia Retirement Systems’s 10x Genomics TXG Stock Holding History

Virginia Retirement Systems’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.38M	Buy	62,003 +6,100	+11%	+$160K	0.01%	496
2026 Q1	$1.19M	Sell	55,903 -7,200	-11%	-$144K	0.01%	538
2025 Q4	$1.03M	Buy	63,103 +2,800	+5%	+$42.3K	0.01%	573
2025 Q3	$705K	Buy	60,303 +6,200	+11%	+$80.8K	﹤0.01%	684
2025 Q2	$627K	Sell	54,103 -20,700	-28%	-$189K	﹤0.01%	703
2025 Q1	$653K	Buy	+74,803	New	+$943K	﹤0.01%	686
2023 Q3	–	Sell	-10,300	Closed	-$575K	–	1036
2023 Q2	$575K	Sell	10,300 -5,400	-34%	-$292K	0.01%	691
2023 Q1	$876K	Buy	15,700 +2,400	+18%	+$112K	0.01%	574
2022 Q4	$485K	Buy	13,300 +4,400	+49%	+$144K	0.01%	832
2022 Q3	$253K	Buy	+8,900	New	+$339K	﹤0.01%	990

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virginia Retirement Systems's TXG Position: Q2 2026 in Review

Virginia Retirement Systems increased its 10x Genomics (TXG) stake by 11% in Q2 2026, buying an estimated $160K and bringing the position to 62,003 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #496.

Virginia Retirement Systems first reported a position in TXG in Q3 2022 and has held it in 10 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Virginia Retirement Systems held 62,003 shares of 10x Genomics worth $2.38M as of Q2 2026.
Virginia Retirement Systems bought 6,100 10x Genomics shares in Q2 2026, an estimated $160K.
10x Genomics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #496 holding.
Virginia Retirement Systems first reported a position in 10x Genomics in Q3 2022 and has held it in 10 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.